KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Enterprise Value (2018 - 2025)

ClearPoint Neuro's Enterprise Value history spans 13 years, with the latest figure at -$38.2 million for Q3 2025.

  • For Q3 2025, Enterprise Value fell 77.17% year-over-year to -$38.2 million; the TTM value through Sep 2025 reached -$38.2 million, down 77.17%, while the annual FY2024 figure was -$20.1 million, 13.14% up from the prior year.
  • Enterprise Value for Q3 2025 was -$38.2 million at ClearPoint Neuro, up from -$41.5 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$12.4 million in Q1 2025 and bottomed at -$64.9 million in Q1 2021.
  • The 5-year median for Enterprise Value is -$37.5 million (2022), against an average of -$37.8 million.
  • The largest annual shift saw Enterprise Value tumbled 293.12% in 2021 before it surged 64.97% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$54.1 million in 2021, then skyrocketed by 30.66% to -$37.5 million in 2022, then soared by 38.32% to -$23.1 million in 2023, then increased by 13.14% to -$20.1 million in 2024, then tumbled by 90.15% to -$38.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Enterprise Value are -$38.2 million (Q3 2025), -$41.5 million (Q2 2025), and -$12.4 million (Q1 2025).